Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Tariq Warsi received his BS in Biological Sciences and PhD in Cell, Molecular, and Developmental Biology from the University of California, Riverside. Tariq was a postdoctoral fellow at Harvard Medical School, has been a Senior Scientist at Silicon Valley startups, and a Staff Scientist at Stanford University. Tariq is currently a Senior Scientist at Amgen within Process Development managing the development and execution of bioassays and immunoassays for the release of large molecule therapeutics for early-phase studies.
The evolution of analytics in CAR-T cell therapy
CAR-T cell therapy is quickly emerging as an approach that has the potential to be a curative treatment for myriad oncology indications. As this immunotherapy advances in the industry, the analytical tools that exist to determine and track critical quality attributes (CQA) must evolve alongside the treatment. Recent advances in the manufacturing processes have led to improved analytical methods that can measure and track CQA with higher accuracy and reliability. Amgen is positioning itself to be a leader in cell and gene therapy, and as part of this effort we will discuss the next generation of analytical approaches that need to evolve to supplement a better understanding of products.
Panel discussion: What can cell therapy manufacturers learn from MAbs to save time and money on the path to commercial scale manufacturing